Genetic Marker Linked to Severe Outcomes Across IBD Subtypes - Medscape

What To Know

This study reports that a specific HLA allele (HLA-DRB1*01:03) is linked not just to IBD risk but to worse clinical courses across subtypes, including surgical outcomes and earlier escalation to advanced treatments. The findings come from a large genotype–phenotype association using biobank data and were published in The Lancet Gastroenterology & Hepatology.

Because the analysis used imputed HLA from genotyping arrays and was limited to patients of primarily European ancestry, the results may not generalize to all populations. The authors suggest carriers might benefit from targeted education about perianal symptoms and earlier reporting to clinicians, but the paper does not provide clinical care guidelines.

If you carry this allele (or are interested in genetic risk), discuss with your care team or a genetics-trained clinician before making any changes to treatment. The associations noted do not prove causation and require further validation in diverse cohorts.